KOSDAQ (Korean Securities Dealers Automated Quotations) is South Korea's growth-oriented secondary exchange, established on July 1, 1996 and modeled after the U.S. NASDAQ. Over 1,700 companies are listed, predominantly in biotech, IT, gaming, entertainment, and emerging technology sectors.
Why It Matters
KOSDAQ represents Korea's innovation economy and serves as the primary listing venue for high-growth companies that don't meet KOSPI's stricter listing criteria. Notable listings include Celltrion (biosimilars), HLB (oncology), Krafton (PUBG developer), Pearl Abyss (Black Desert), Kakao Games, and Alteogen (biotech).
The Dot-Com Bubble & Aftermath
KOSDAQ experienced one of the most dramatic bubbles in market history. During the dot-com mania, the index surged from ~500 in early 1999 to a peak of approximately 2,834 in March 2000 β a 5x gain in barely a year. The subsequent collapse was devastating: by 2004, the index had fallen to roughly 324, an 88% decline from peak. Many retail investors lost their life savings, leading to lasting cultural trauma around "KOSDAQ speculation."
Biotech Cycles
KOSDAQ has experienced repeated biotech-driven rallies. In 2015β2016, biotech stocks (Hanmi Pharmaceutical, Celltrion) drove major index gains before a sharp correction as clinical trial results disappointed. The cycle repeated in 2020β2021 with COVID vaccine and diagnostic plays.
The "Donghak Ant" Movement (2020)
During the COVID crash, Korean retail investors β dubbed "Donghak Ants" (λνκ°λ―Έ, referencing an 1894 peasant uprising) β poured unprecedented amounts into KOSDAQ stocks. Individual investor net purchases on KOSDAQ exceeded β©20 trillion in 2020 alone (source: KRX), fundamentally changing market dynamics.
Characteristics
Higher volatility than KOSPI, with individual investors comprising over 80% of trading volume (vs. ~50% on KOSPI). Single biotech stocks can move 15β30% on clinical trial announcements or FDA decisions. Short-selling restrictions (periodically imposed by Korean regulators) tend to amplify KOSDAQ's upside momentum.
Market Impact
KOSDAQ outperformance signals risk-on sentiment and retail investor enthusiasm in Korea. It is widely viewed as a barometer for speculative appetite in Asian markets. The KOSDAQ/KOSPI ratio is tracked by strategists as a gauge of growth-vs-value rotation in the Korean market.